Tracy L. Taylor

Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors

Chunjian Liu, James C. Lin, Ryan Moslin et al. · ACS Medicinal Chemistry Letters · 2019 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agents

Douglas G. Batt, Joseph J. Petraitis, Susan R. Sherk et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P₁ Receptor Modulator in Clinical Trials

T. G. Murali Dhar, Hai‐Yun Xiao, Jenny Xie et al. · ACS Medicinal Chemistry Letters · 2016 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)—A potent and efficacious p38α MAP kinase inhibitor

John Hynes, Hong Wu, Sidney Pitt et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Periodic, Partial Inhibition of IκB Kinase β-Mediated Signaling Yields Therapeutic Benefit in Preclinical Models of Rheumatoid Arthritis

Kathleen M. Gillooly, Mark A. Pattoli, Tracy L. Taylor et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 26 citations

Medicine, Medicinal Chemistry, Pharmacology +13